AnaptysBio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AnaptysBio and other ETFs, options, and stocks.

About ANAB

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. 

CEO
Daniel R. Faga
CEODaniel R. Faga
Employees
104
Employees104
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2005
Founded2005
Employees
104
Employees104

ANAB Key Statistics

Market cap
1.65B
Market cap1.65B
Price-Earnings ratio
-21.48
Price-Earnings ratio-21.48
Dividend yield
Dividend yield
Average volume
386.71K
Average volume386.71K
High today
$63.47
High today$63.47
Low today
$55.51
Low today$55.51
Open price
$59.97
Open price$59.97
Volume
949.94K
Volume949.94K
52 Week high
$63.47
52 Week high$63.47
52 Week low
$15.12
52 Week low$15.12

Stock Snapshot

The current AnaptysBio(ANAB) stock price is $57.28, with a market capitalization of 1.65B. The stock trades at a price-to-earnings (P/E) ratio of -21.48.

On 2026-03-05, AnaptysBio(ANAB) stock moved within a range of $55.51 to $63.47. With shares now at $57.28, the stock is trading +3.2% above its intraday low and -9.8% below the session's peak.

Trading volume for AnaptysBio(ANAB) stock has reached 949.94K, versus its average volume of 386.71K.

Over the past 52 weeks, AnaptysBio(ANAB) stock has traded between a high of $63.47 and a low of $15.12.

Over the past 52 weeks, AnaptysBio(ANAB) stock has traded between a high of $63.47 and a low of $15.12.

ANAB News

TipRanks 17h
Risks Loom for AnaptysBio’s Proposed Breakup: Market Value, Volatility and Execution Challenges Highlighted

AnaptysBio (ANAB) has disclosed a new risk, in the Corporate Activity and Growth category. AnaptysBio may fail to realize the expected operational, financial,...

TipRanks 2d
AnaptysBio provides update on potential spin-off of biopharma operations

AnaptysBio (ANAB) provided an update on the potential spin-off of its biopharma operations. Intention to separate biopharma operations from substantial royalty...

Nasdaq 2d
Commit To Buy AnaptysBio At $35, Earn 15.9% Annualized Using Options

Investors considering a purchase of AnaptysBio Inc (Symbol: ANAB) stock, but cautious about paying the going market price of $53.97/share, might benefit from co...

Commit To Buy AnaptysBio At $35, Earn 15.9% Annualized Using Options

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%

People also own

Based on the portfolios of people who own ANAB. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.